IP Library › Assignment 025709/0994
Patent Assignment
Reel/Frame 025709/0994

Change of Name

Recorded: 2011-01-28 Pages: 4
Assignor
PGXHEALTH, LLC
Executed: 2011-01-06
Assignee
TROVIS PHARMACEUTICALS, LLC
ONE GATEWAY CENTER, SUITE 702, NEWTON, MASSACHUSETTS, 02458
Covered Properties (29)
Substituted 8-Heteroaryl Xanthines
Patent: 7,342,006 →
Application: 10/923,592 →
Publication: US 2005/0065341
Selective Antagonists of A2A Adenosine Receptors
Patent: 7,217,702 →
Application: 11/097,251 →
Publication: US 2005/0282831
Pyridyl Substituted Xanthines
Patent: 7,601,723 →
Application: 11/362,387 →
Publication: US 2007/0072843
Methods for the Synthesis of Unsymmetrical Cycloalkyl Substituted Xanthines
Patent: 7,598,379 →
Application: 11/362,390 →
Publication: US 2007/0105821
Derivatives of 8-Substituted Xanthines
Patent: 7,579,348 →
Application: 11/362,392 →
Publication: US 2007/0249598
Pyrazolyl Substituted Xanthines
Patent: 7,618,962 →
Application: 11/362,393 →
Publication: US 2007/0066631
Substituted Aryl Piperidinylalkynyladenosines as A2AR Agonists
Patent: 7,589,076 →
Application: 11/804,165 →
Publication: US 2007/0270373
Substituted 8-[6-Amino-3-Pyridyl]Xanthines
Patent: 7,884,100 →
Application: 11/811,823 →
Publication: US 2008/0004292
Selective Antagonists of A2A Adenosine Receptors
Patent: 7,985,754 →
Application: 11/879,133 →
Publication: US 2009/0118309
Pyrrolo[3,2-D] Pyrimidines That Are Selective Antagonists of A2BADENOSINE Receptors
Patent: 7,470,697 →
Application: 11/897,678 →
Publication: US 2008/0125425
Substituted 8-Heteroaryl Xanthines
Patent: 7,732,455 →
Application: 11/956,876 →
Publication: US 2008/0200456
Methods for Preparing 2-Alkynyladenosine Deriviatives
Patent: 7,671,191 →
Application: 11/975,080 →
Publication: US 2008/0177055
Adenosine Derivative Formulations for Medical Imaging
Application: 12/014,949 →
Publication: US 2008/0219927
Agonists of A2A Adenosine Receptors for Treating Recurrent Tumor Growth in the Liver Following Resection
Application: 12/102,185 →
Publication: US 2008/0262001
Pyrrolo[3,2-D]Pyrimidines That Are Selective Antagonists of A2B Adenosine Receptors
Patent: 8,349,848 →
Application: 12/266,259 →
Publication: US 2009/0082347
Substituted 8-[6-Amino-3PYRIDYL]Xanthines
Patent: 7,875,608 →
Application: 12/337,010 →
Publication: US 2009/0163491
Substituted 4-{3-[6-Amino-9-(3, 4-Dihydroxy-Tetrahydro-Furan-2-Yl)-9H-Purin-2-Yl]-Prop-2-Ynyl}-Piperidine-1-Carboxylic Acid Esters as A2AR Agonists
Patent: 8,293,720 →
Application: 12/338,369 →
Publication: US 2009/0162292
Intrathecal Treatment of Neuropathic Pain with A2AR Agonists
Application: 12/351,209 →
Publication: US 2009/0181920
Therapeutic Agent for Glaucoma Containing Adenosine Derivative as Active Ingredient
Application: 12/450,832 →
Publication: US 2010/0093770
Substituted Aryl Piperidinylalkynyladenosines as A2AR Agonists
Patent: 7,888,329 →
Application: 12/501,750 →
Publication: US 2009/0280059
Methods for the Synthesis of Unsymmetrical Cycloalkyl Substituted Xanthines
Patent: 8,420,813 →
Application: 12/503,373 →
Publication: US 2010/0004445
Pyrazolyl Substituted Xanthines
Patent: 8,153,628 →
Application: 12/507,472 →
Publication: US 2010/0120765
Substituted 8-Heteroaryl Xanthines
Application: 12/762,711 →
Publication: US 2010/0273780
Substituted 4-{3-[6-Amino-9-(3, 4-Dihydroxy-Tetrahydro-Furan-2-Yl)-9H-Purin-2-Yl]-Prop-2-Ynyl}-Piperidine-1-Carboxylic Acid Esters as A2AR Agonists
Patent: 8,252,767 →
Application: 12/809,381 →
Publication: US 2011/0003765
Alkoxy-Carbonyl-Amino-Alkynyl-Adenosine Compounds and Derivatives Thereof as A2AR Agonists
Patent: 8,263,762 →
Application: 12/827,932 →
Publication: US 2011/0003766
Agonists of A2A Adenosine Receptors for Treating Recurrent Tumor Growth
Patent: 8,551,972 →
Application: 12/940,457 →
Publication: US 2011/0166094
Substituted 8-[6-Amino-3-Pyridyl]Xanthines
Patent: 8,258,142 →
Application: 12/967,876 →
Publication: US 2011/0082139
Substituted Aryl Piperidinylalkynyladenosines as A2AR Agonists
Patent: 8,222,228 →
Application: 12/981,308 →
Publication: US 2011/0091385
Method of Treating Multiple Sclerosis with Adenosine Receptor Agonists
Application: 61/334,034 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 3, 2004
From: WANG, GUOQUAN; RIEGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 015425/0229 →
Assignment of Assignor's Interest Sep 2, 2005
From: BEAUGLEHOLE, ANTHONY; RIEGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 016487/0660 →
Assignment of Assignor's Interest Apr 20, 2007
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.; WANG, GUOQUAN
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019198/0496 →
Assignment of Assignor's Interest Apr 20, 2007
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.; WANG, GUOQUAN
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019198/0328 →
Assignment of Assignor's Interest Apr 20, 2007
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.; WANG, GUOQUAN
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019198/0204 →
Assignment of Assignor's Interest Apr 20, 2007
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.; WANG, GUOQUAN
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019198/0129 →
Assignment of Assignor's Interest Jul 12, 2007
From: RIEGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 019555/0937 →
Assignment of Assignor's Interest Mar 26, 2008
From: WANG, GUOQUAN; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 020708/0784 →
Assignment of Assignor's Interest Mar 28, 2008
From: WANG, GUOQUAN; RIEGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 020729/0289 →
Assignment of Assignor's Interest May 2, 2008
From: BEAUGLEHOLE, ANTHONY; SCHMIDTMANN, FRANK W.; RIEGER, JAYSON M.; WATKINS, LINDA
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 020896/0198 →
Assignment of Assignor's Interest May 30, 2008
From: WANG, GUOQUAN; RIEGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 021031/0742 →
Assignment of Assignor's Interest Aug 12, 2008
From: BEAUGLEHOLE, ANTHONY; REIGER, JAYSON M.; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 021377/0599 →
Assignment of Assignor's Interest Nov 20, 2008
From: ADENOSINE THERAPEUTICS, LLC
To: PGXHEALTH, LLC
Reel/Frame 021867/0071 →
Assignment of Assignor's Interest Jan 8, 2009
From: ADENOSINE THERAPEUTICS, LLC
To: PGXHEALTH, LLC
Reel/Frame 022075/0734 →
Assignment of Assignor's Interest Apr 20, 2009
From: KRANENBURG, ONNO; VAN DER BILT, JARMILA; RINKES, INNE BOREL; RIEGER, JAYSON M
To: ADENOSINE THERAPEUTICS, LLC
Reel/Frame 022568/0395 →
Assignment of Assignor's Interest Apr 20, 2009
From: ADENOSINE THERAPEUTICS
To: PGXHEALTH, LLC
Reel/Frame 022568/0447 →
Assignment of Assignor's Interest Jun 7, 2011
From: WANG, GUOQUAN; THOMPSON, ROBERT D.
To: ADENOSINE THERAPEUTICS LLC
Reel/Frame 026400/0078 →
Merger Dec 14, 2011
From: TROVIS PHARMACEUTICALS LLC
To: TROVIS PHARMACEUTICALS HOLDINGS, INC.
Reel/Frame 027386/0851 →
Assignment of Assignor's Interest Dec 14, 2011
From: DOGWOOD PHARMACEUTICALS, INC.
To: FOREST LABORATORIES HOLDINGS LIMITED
Reel/Frame 027386/0509 →
Merger Dec 14, 2011
From: TROVIS PHARMACEUTICALS HOLDINGS, INC.
To: CLINICAL DATA, INC.
Reel/Frame 027386/0494 →
Assignment of Assignor's Interest Dec 14, 2011
From: CLINICAL DATA, INC.
To: DOGWOOD PHARMACEUTICALS, INC.
Reel/Frame 027386/0502 →
Merger Jan 9, 2012
From: TROVIS PHARMACEUTICALS LLC
To: TROVIS PHARMACEUTICALS HOLDINGS, INC.
Reel/Frame 027499/0121 →
Merger Jan 9, 2012
From: TROVIS PHARMACEUTICALS HOLDINGS, INC.
To: CLINICAL DATA, INC.
Reel/Frame 027499/0196 →
Assignment of Assignor's Interest Jan 9, 2012
From: CLINICAL DATA, INC.
To: DOGWOOD PHARMACEUTICALS, INC.
Reel/Frame 027499/0253 →
Assignment of Assignor's Interest Jan 9, 2012
From: DOGWOOD PHARMACEUTICALS, INC.
To: FOREST LABORATORIES HOLDINGS LIMITED
Reel/Frame 027499/0300 →